Publications & Resources

Get insights and guidance from MLMIC and other leading sources on medical professional liability, risk management, and more.

Tag: patient care

New Research Highlights Concerns Related to Use of Chloroquine, Hydroxychloroquine and Azithromycin for Treating COVID-19 Patients

New research indicates there is weak evidence that chloroquine, hydroxychloroquine and azithromycin can effectively treat and prevent COVID-19 and the drugs carry potentially serious risks.

New York Public Health Law Provides Immunity for Facilities and Professionals Responding to COVID-19

New York has enacted the Emergency Disaster Treatment Protection Act, a new statute in the Public Health Law that provides healthcare facilities and professionals immunity from civil or criminal liability when delivering care related to COVID-19.

Cuomo Executive Order Extends the Suspension and Modifications of Healthcare Regulations during COVID-19 Pandemic

A new Executive Order issued by New York Governor Cuomo continues certain healthcare and malpractice liability directives outlined in previous Executive Orders that address the COVID-19 pandemic.

Evidence-Based Recommendations to Help Care for COVID-19 Patients in the ICU

New recommendations issued by an international research team offer clinical practice guidelines for physicians treating intensive care unit patients with COVID-19.

Legal Risks and Tips for Volunteer Physicians During the COVID-19 Pandemic

MLMIC’s tips and legal risks for policyholders to consider when volunteering during the COVID-19 pandemic.

Experts Say There is No Evidence NSAIDs are Unsafe for COVID-19 Patients

New research refutes speculation that NSAIDs can negatively impact patients with COVID-19.

New Flexibility from CMS Will Help Hospitals Manage the COVID-19 Pandemic

New CMS waivers grant hospitals and healthcare systems a number of temporary flexibilities designed to help manage the COVID-19 pandemic.

When Appropriate, FDA Permits Use of Hydroxychloroquine and Chloroquine to Treat COVID-19

The FDA issued emergency use authorization for anti-malarial drugs hydroxychloroquine and chloroquine to treat COVID-19 patients when deemed appropriate by a healthcare provider.

Cuomo Executive Order Grants Immunity to Healthcare Providers During COVID-19 Emergency

New York Governor Andrew Cuomo has issued an Executive Order granting immunity to healthcare providers responding to the COVID-19 pandemic. Here’s MLMIC’s statement on its meaning and significance.

Guidance on Using Telemedicine for Coronavirus

Physicians are reminded to adhere to New York State policy when delivering telehealth services for coronavirus.